Armata Pharmaceuticals, Inc. (ARMP)

2.6000 +0.0700 (+2.77%) As of 09:41AM EDT. Market open.

Armata Pharmaceuticals, Inc.

5005 McConnell Avenue
Los Angeles, CA 90066
United States
310 665 2928
https://www.armatapharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 66

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Mina Pastagia M.D., MS	Chief Medical Officer	537.6k	N/A	1975
Dr. Deborah L. Birx M.D.	CEO & Director	N/A	N/A	1957
Mr. Richard Rychlik	VP, Corporate Controller & Principal Financial Officer	N/A	N/A	1956
Mr. Peter Hubbard	Vice President of Operations	N/A	N/A	N/A
Dr. Pierre Kyme Ph.D.	Senior Vice President of Business & Corporate Development	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Los Angeles, California.

Corporate governance

Armata Pharmaceuticals, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.